Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells
- PMID: 9414252
- DOI: 10.1089/hum.1997.8.17-2031
Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells
Abstract
Retroviral vectors are efficient tools for gene transfer studies. Their major advantage is that they can permanently integrate the transgene into the target cell's genome. However, because of the compulsory nuclear expression phase of their life cycle, it can be difficult for retroviruses to carry complex expression cassettes. In a attempt to mimic the structural features of most eukaryotic genes and obtain a potentially self-amplifying system for retrovirus production, we tested the feasibility of Semliki Forest virus (SFV) expression to mediate cytoplasmic synthesis of retrovirus vector RNA. An equivalent of a retrovirus virion RNA (retrovirus vector cassette, RVC) was cloned under the SFV 26S promoter, and full-length chimeric SFV-RVC RNA was produced in vitro. This RNA was introduced into retrovirus packaging cells, either via electroporation or transduction in SFV virions, and supernatants were analyzed for the presence of biologically active retroviruses. We demonstrate that this strategy can be used for cytoplasmic retrovirus production. The resulting viral particles are fully functional; they can transduce target cells, undergo reverse transcription, and integrate into genomic DNA. We also demonstrate that the SFV virion-based RVC delivery into packaging cells can yield high transient titers, in this case more than 10(5) G418R cfu/ml. This study shows that a simple, one-plasmid, heterologous viral RNA production system can be used to create functional retroviral RNA outside the cell nucleus.
Similar articles
-
Mobilization of full-length Semliki Forest virus replicon by retrovirus particles.J Virol. 2006 Oct;80(19):9889-95. doi: 10.1128/JVI.00664-06. J Virol. 2006. PMID: 16973593 Free PMC article.
-
Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.J Virol. 2002 Feb;76(3):1236-43. doi: 10.1128/jvi.76.3.1236-1243.2002. J Virol. 2002. PMID: 11773399 Free PMC article.
-
Expression of proteins using Semliki Forest virus vectors.Curr Protoc Mol Biol. 2001 May;Chapter 16:Unit16.20. doi: 10.1002/0471142727.mb1620s29. Curr Protoc Mol Biol. 2001. PMID: 18265128
-
Semliki Forest virus vectors for gene therapy.Expert Opin Biol Ther. 2003 Aug;3(5):771-7. doi: 10.1517/14712598.3.5.771. Expert Opin Biol Ther. 2003. PMID: 12880377 Review.
-
Vaccinia viral/retroviral chimeric vectors.Curr Gene Ther. 2004 Dec;4(4):417-26. doi: 10.2174/1566523043346101. Curr Gene Ther. 2004. PMID: 15578991 Review.
Cited by
-
Suppression of TGF-beta1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells.J Neurooncol. 1999 May;43(1):27-34. doi: 10.1023/a:1006289901702. J Neurooncol. 1999. PMID: 10448868
-
A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.PLoS One. 2013 Oct 9;8(10):e75574. doi: 10.1371/journal.pone.0075574. eCollection 2013. PLoS One. 2013. PMID: 24130722 Free PMC article.
-
Mobilization of full-length Semliki Forest virus replicon by retrovirus particles.J Virol. 2006 Oct;80(19):9889-95. doi: 10.1128/JVI.00664-06. J Virol. 2006. PMID: 16973593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources